NCT04680429View on ClinicalTrials.gov

A Single and Multiple Ascending and Food Effect Study of RP7214, a DHODH Inhibitor in Healthy Adult Subjects

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

December 29, 2020

Primary Completion Date

July 17, 2021

Study Completion Date

July 19, 2021

Conditions

Healthy Volunteers

Interventions

DRUG

RP7214

Participants will receive single and multiple ascending doses of RP7214

DRUG

Placebo

Participants will receive single and multiple ascending doses of matching placebo

Trial Locations (2)

58104

Rhizen Investigational Site, Fargo

89121

Rhizen Investigational Site, Las Vegas

All Listed Sponsors

lead

Rhizen Pharmaceuticals SA

INDUSTRY

NCT04680429 - A Single and Multiple Ascending and Food Effect Study of RP7214, a DHODH Inhibitor in Healthy Adult Subjects | Biotech Hunter | Biotech Hunter